Know Cancer

or
forgot password
  • cancer clinical trials in bellevue, WA

  • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Breast Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Overlake Cancer Center at Overtake Hospital Medical Center
    Bellevue, Washington 98004
    Breast Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Overlake Cancer Center at Overtake Hospital Medical Center
    Bellevue, Washington 98004
    Colorectal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Breast Cancer
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Bladder Cancer
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Lake Washington Vascular, Pllc
    Bellevue, Washington 98004
    Venous Thrombosis
    Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
    Overlake Internal Medicine Associates
    Bellevue, Washington 98004
    Breast Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Overlake Hospital Medical Center
    Bellevue, Washington 98004
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic Breast Cancer
    Overlake Hospital Medical Center

    Trial Locations
    Overlake Hospital Medical Center
    Overlake Cancer Center
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Lung Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Ovarian Cancer, Sarcoma
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Colorectal Cancer, Precancerous Condition
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Lung Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Kidney Cancer
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Prostate Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Swedish Cancer Institute-Eastside Hematology/Oncology
    Bellevue, Washington 98005
    Chronic Myeloid Leukemia
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Overlake Hospital Medical Center

    Trial Locations
    Overlake Hospital Medical Center
    Overlake Internal Medicine Associates
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Integrative Oncology Outcomes Study in Breast Cancer
    Red Cedar Wellness Center
    Bellevue, Washington 98004
    Breast Cancer
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Caris Biorepository Research Protocol
    Overlake Hospital
    Bellevue, Washington 98004
    Cancer
    Phase 3 Study of Fibrocaps™ in Surgical Bleeding
    Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Mild or Moderate Surgical Bleeding
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Fatigue
    A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
    "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
    Bellevue, Washington
    Colorectal Cancer
    Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
    Northwest Clinical Research Center
    Bellevue, Washington 98004
    Low Back Pain, Migraine, Diabetic Neuropathies, Osteoarthritis
    BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
    Northwest Gastroenterology Associates
    Bellevue, Washington 98004
    Colon Cancer
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Northwest Gastroenterology Associates
    Bellevue, Washington 98004
    Crohn's Disease
    PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening
    Northwest Gastroenterology Associates
    Bellevue, Washington 98004
    Colorectal Cancer
    A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases
    Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Metastatic Non-Small Cell Lung Cancer
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    Overlake Cancer Center at Overlake Hospital Medical Center
    Bellevue, Washington 98004
    Colorectal Cancer, Metastatic Cancer
    Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
    Northwest Gastroenterology Associates
    Bellevue, Washington 98004
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer